Owen Adams Catherine

CIK 00018168383 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001816838

Recent Transactions

32 trades

Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2026-06-18+14,950→ 14,950 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2026-06-18+2,927→ 2,927 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2026-06-18−2,816→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-06-18+2,816→ 10,865 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-06-13+1,976→ 8,049 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2026-06-13−1,976→ 0 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2026-03-25$21.47/sh−11,641→ 14,803 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2026-03-24−23,509→ 70,530 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2026-03-24+23,509→ 26,444 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2026-03-06+76,509→ 76,509 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (Right to Buy)
2026-03-06+263,005→ 263,005 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-20+2,120→ 6,073 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-06-20−2,120→ 0 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-06-18+15,768→ 15,768 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-06-18+2,816→ 2,816 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-13+1,977→ 3,953 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-06-13−1,977→ 1,976 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-03-24+94,039→ 94,039 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (Right to Buy)
2025-03-24+319,976→ 319,976 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (Right to Buy)
2024-09-23+353,261→ 353,261 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-06-20+2,120→ 2,120 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2024-06-20+11,774→ 11,774 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-06-13+1,976→ 1,976 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-06-13−1,976→ 3,953 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2024-06-06+75,000→ 75,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2023-06-13+33,177→ 33,177 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2023-06-13+5,929→ 5,929 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2023-06-08+53,500→ 53,500 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2022-06-08+32,000→ 32,000 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2021-06-09+14,439→ 14,439 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2020-07-29+28,879→ 28,879 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2020-07-29+28,879→ 28,879 total

Companies

Recent Filings

Address

C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET

CAMBRIDGE, MA, 02139

View on SEC.gov